Skin AE Management

Help to prevent and manage dermatologic adverse events (dAEs)

Additional steps that may reduce the risk of dAEs

Identifying key risk factors

Causes and management of common dAEs

Explore Optune Gio FAQs.

References: 1. Lacouture ME, Davis ME, Elzinga G, et al. Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma. Semin Oncol. 2014;41(3 suppl 4):S1-14. 2. Lacouture ME, Anadkat MJ, Ballo MT, et al. Prevention and management of dermatologic adverse events associated with Tumor Treating Fields in patients with glioblastoma. Front Oncol. 2020;10:1045. doi: 10.3389/fonc.2020.01045

Skin AE Management

Help to prevent and manage dermatologic adverse events (dAEs)

Help prevent dAEs to maximize time on therapy

Additional steps that may reduce the risk of dAEs

Tips to help prevent skin irritation and potential infection¹

Identifying key risk factors

Key risk factors correlated with dAEs¹:

Causes and management of common dAEs

Treatment options for dAEs are dependent upon the type and severity of the dAE.²

Explore Optune Gio FAQs.

Skin AE Management

Help to prevent and manage dermatologic adverse events (dAEs)

Help prevent dAEs to maximize time on therapy

Additional steps that may reduce the risk of dAEs

Tips to help prevent skin irritation and potential infection1

Identifying key risk factors

Key risk factors correlated with dAEs1:

Causes and management of common dAEs

Treatment options for dAEs are dependent upon the type and severity of the dAE.2

Explore Optune Gio FAQs.

Tips to help prevent skin irritation and potential infection¹

Key risk factors correlated with dAEs¹:

Treatment options for dAEs are dependent upon the type and severity of the dAE.²